Eelco D. K.
- Country
- The Netherlands
- Department
- Leiden University Medical Centre
Research Overview
- Evaluation of Diamyd (Recombinant Human Glutamate Decarboxylase 2) and Colecalciferol in Preserving Beta Cell Function in HLA DR3-DQ2 Positive Type 1 Diabetes
- Evaluation of the Safety, Tolerability, and Efficacy of Zimislecel (VX-880) in Type 1 Diabetes Mellitus with Impaired Hypoglycemic Awareness and Severe Hypoglycemia
- Evaluation of Safety, Tolerability, and Efficacy of VX-264 Implant in Patients with Type 1 Diabetes Mellitus
Data & Insights
Has run more than one trial at 16 of 104 partner sites.
Specializations
Diabetes Management
This investigator specializes in the treatment of Type 1 diabetes mellitus, with particular focus on innovative therapeutic approaches for patients with varying clinical presentations.
- Beta cell function preservation
- Glycemic control optimization
- Genetic factor considerations
Research interests include assessment of novel treatments for newly diagnosed diabetes patients, particularly those with specific genetic markers.
Advanced Therapeutics
The investigator focuses on evaluating cutting-edge therapeutic interventions for diabetes management, including novel pharmaceutical compounds and their applications.
- Safety and tolerability assessments
- Treatment efficacy evaluation
- Therapeutic response monitoring
Their work encompasses comprehensive evaluation of new therapeutic agents for diabetes treatment.
Specialized Diabetes Complications
Expert focus on complex diabetes presentations, particularly impaired hypoglycemic awareness and severe hypoglycemia management in Type 1 diabetes patients.
- Hypoglycemia management
- Advanced treatment interventions
- Complex case management
Specialized interest in developing solutions for patients with complicated diabetes presentations requiring advanced therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.